feedback

Course Director

Matthew R. Weir, MD
Matthew R. Weir, MD

University of Maryland School of Medicine
Baltimore, Maryland

Accredited by

Purdue University

Activity Description and Educational Objectives

In this activity, an expert discusses the management of anemia in patients with chronic kidney disease (CKD) and closely reviews the clinical potential of hypoxia-inducible factor prolyl hydroxylase (HIF-PH) inhibitors in treating CKD-associated anemia.

Upon completion of this activity, participants will be able to:
  • Describe the clinical consequences of anemia in patients with chronic kidney disease (CKD)
  • Recognize the rationale for targeting hypoxia-inducible factor (HIF) stabilization with HIF prolyl-hydroxylase (PH) inhibitors as a treatment strategy for anemia because of CKD
  • Compare current and emerging treatments for CKD-associated anemia in terms of their mechanisms of action, efficacy, and safety
  • Identify patients with anemia because of CKD who would likely derive benefit from treatment with a HIF-PH inhibitor

Target Audience

This activity has been designed to meet the educational needs of nephrologists, cardiologists, PCPs, endocrinologists, pharmacists, and other clinicians involved in the care of patients with CKD-associated anemia.

Requirements for Successful Completion

In order to receive credit, participants must view the activity and complete the post-test and evaluation form. There are no pre-requisites and there is no fee to participate in this activity or to receive CME/CPE credit. Statements of Credit are awarded upon successful completion of the post-test and evaluation form.

Media: Enduring Material
Release and Expiration Dates: December 18, 2019 - December 17, 2020
Time to Complete: 60 minutes

Faculty and Disclosure / Conflict of Interest Policy

All faculty AND staff involved in the planning, review or presentation of continuing education activities provided by Purdue University College of Pharmacy are required to disclose to the audience any relevant commercial financial affiliations related to the content of the presentation or enduring material. Full disclosure of all commercial relationships must be made in writing to the audience prior to the activity.

Chair

Matthew R. Weir, MD
Professor of Medicine
Chief, Division of Nephrology
Department of Medicine
University of Maryland School of Medicine
Baltimore, Maryland

Matthew R. Weir, MD, has a financial interest/relationship or affiliation in the form of:
Consultant and/or Advisor for AbbVie Inc.; Akebia Therapeutics; AstraZeneca; Boehringer Ingelheim Pharmaceuticals, Inc.; Boston Scientific Corporation; Janssen Pharmaceuticals, Inc. Merck & Co., Inc.; Relypsa Inc.; and Vifor Pharma Management Ltd.

Medical Director

Kathryn B. Charalambous, PhD
PVI, PeerView Institute for Medical Education

Kathryn B. Charalambous, PhD, has no financial interests/relationships or affiliations in relation to this activity.

All additional planning committee members and reviewers, PVI, PeerView Institute for Medical Education, Inc. staff, and Purdue University College of Pharmacy staff have no relationships to disclose.

Providership, Credit, and Support

Physicians

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Purdue University College of Pharmacy and PVI, PeerView Institute for Medical Education. Purdue University College of Pharmacy, an equal access/equal opportunity institution, is accredited by the ACCME to provide continuing medical education for physicians.

The Purdue University College of Pharmacy designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Pharmacists

ACPEPurdue University College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This is a knowledge-based, continuing education activity of Purdue University, an equal access/equal opportunity institution. Universal Activity Number (UAN): 0018-9999-19-108-H01-P, 1.0 contact hours (0.1 CEUs).
Release Date: December 18, 2019 Expiration Date: December 17, 2020

Providership


This CME/CPE activity is jointly provided by Purdue University College of Pharmacy and PVI, PeerView Institute for Medical Education.

Support

This activity is supported by an educational grant from AstraZeneca Pharmaceuticals LP in collaboration with FibroGen.

Disclosure of Unlabeled Use

The faculty of this educational activity may include discussions of products or devices that are not currently labeled for use by the FDA. Faculty members have been advised to disclose to the audience any reference to an unlabeled or investigational use.

No endorsement of unapproved products or uses is made or implied by coverage of these products or uses in our reports. No responsibility is taken for errors or omissions in reports. For approved prescribing information, please consult the manufacturer’s product labeling.

About This CME/CPE Activity

PVI, PeerView Institute for Medical Education, and Purdue University College of Pharmacy are responsible for the selection of this activity's topics, the preparation of editorial content, and the distribution of this activity. The preparation of PeerView activities is supported by educational grants subject to written agreements that clearly stipulate and enforce the editorial independence of PVI and Purdue University College of Pharmacy. Our activities may contain references to unapproved products or uses of these products in certain jurisdictions. For approved prescribing information, please consult the manufacturer's product labeling. No endorsement of unapproved products or uses is made or implied by coverage of these products or uses in our activities. No responsibility is taken for errors or omissions in activities.

The materials presented here are used with the permission of the authors and/or other sources. These materials do not necessarily reflect the views of PeerView or any of its partners, providers, and/or supporters.

Copyright © 2000-2019, PeerView

Suggest a CME Activity

Please provide below the URL and description of an activity you would like to add to OpenCME. You are welcome to add activities as often as you like. To prevent spam or other abuse, activities are reviewed by our editorial team before appearing on OpenCME.

OpenCME for Publishers

Please use the form below if you would like to offer your website visitors high-quality CME content by adding the OpenCME Widget to one or more of your pages.

Send Email to a Colleague

To share this activity with one or more colleagues, enter their e-mail addresses below. To include a personal message, simply overwrite the suggested text below.

(So your recipient knows it's from you.)
Enter multiple recipients separated by a space.
Optionally, replace/modify in the box above the message that will be sent to your colleague(s) with a link to download this app.